Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Non-Standardized Plant Allergenic Extract [EPC]
Sus Scrofa Spleen is a biological substance derived from porcine spleen, utilized primarily in glandular therapy and non-standardized allergenic extracts for its purported immunomodulatory and hormonal properties.
Name
Sus Scrofa Spleen
Raw Name
SUS SCROFA SPLEEN
Category
Non-Standardized Plant Allergenic Extract [EPC]
Drug Count
53
Variant Count
55
Last Verified
February 17, 2026
About Sus Scrofa Spleen
Sus Scrofa Spleen is a biological substance derived from porcine spleen, utilized primarily in glandular therapy and non-standardized allergenic extracts for its purported immunomodulatory and hormonal properties.
Detailed information about Sus Scrofa Spleen
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Sus Scrofa Spleen.
As a therapeutic agent, Sus Scrofa Spleen belongs to a class of biological products that are often not standardized for specific potency, meaning the concentration of active peptides and enzymes may vary between batches. Despite this, it is frequently utilized in homeopathic preparations, dietary supplements, and specific allergenic extracts intended for desensitization or immune support. The FDA's history with porcine-derived products is extensive, though Sus Scrofa Spleen specifically often falls under the 'grandfathered' status of homeopathic pharmacopeias or is regulated as a component of complex biological mixtures. Patients should understand that while the spleen is a central organ in the lymphatic system, the therapeutic application of its extract requires careful clinical oversight to ensure safety and efficacy.
At the molecular level, Sus Scrofa Spleen acts as a complex biological signaling matrix. The mechanism of action is multifaceted, involving several Established Pharmacologic Classes (EPC) and Mechanisms of Action (MoA) as defined in clinical databases. Most notably, it is characterized as an Acetylcholine Release Inhibitor [MoA]. By modulating the release of acetylcholine at the neuromuscular junction or within the autonomic nervous system, it may influence smooth muscle contraction and inflammatory signaling pathways.
Furthermore, research into splenic extracts has identified specific peptides such as tuftsin (a tetrapeptide) and splenopentin. These compounds are known to enhance the phagocytic activity of macrophages and neutrophils, effectively acting as immunomodulators. The extract also exhibits Estrogen Receptor Agonist [MoA] and Androgen Receptor Agonist [MoA] activities. This suggests that components within the porcine spleen may bind to steroid hormone receptors, potentially influencing endocrine balance and metabolic rate. Additionally, its 'Acidifying Activity' and 'Calcium Chelating Activity' suggest a role in modulating the systemic pH and mineral homeostasis, which are critical for enzymatic functions and bone density.
Understanding the pharmacokinetics of a complex biological extract like Sus Scrofa Spleen is challenging because it contains hundreds of bioactive molecules rather than a single synthetic compound.
Sus Scrofa Spleen is utilized in several clinical contexts, though many remain in the realm of complementary and alternative medicine (CAM) or specific allergenic immunotherapy:
Sus Scrofa Spleen is available in several preparations, often as part of a multi-ingredient formula:
> Important: Only your healthcare provider can determine if Sus Scrofa Spleen is right for your specific condition. The complexity of its biological makeup necessitates professional guidance to avoid adverse immunological or hormonal effects.
The dosage of Sus Scrofa Spleen varies significantly based on the concentration of the extract and the intended use. Because it is often part of a non-standardized product, there is no single 'gold standard' dose. However, common ranges observed in clinical practice include:
Sus Scrofa Spleen is generally not recommended for use in pediatric populations unless specifically directed by a specialist such as a pediatric immunologist or homeopath. The potential for these extracts to interfere with developing endocrine systems (due to androgen and estrogen receptor activity) or to trigger undiagnosed animal protein allergies makes them high-risk for children. If prescribed, doses are typically weight-based and significantly lower than adult doses.
Patients with significant renal impairment should exercise caution. While the primary components are peptides and amino acids, the 'Calcium Chelating Activity' and 'Acidifying Activity' could potentially stress compromised kidneys. Dose reductions of 50% may be considered for patients with a GFR below 30 mL/min.
There are no specific guidelines for hepatic impairment; however, since the liver is responsible for processing amino acids and regulating the hormonal signals triggered by this extract, patients with cirrhosis or hepatitis should be monitored for changes in liver function tests (LFTs).
Elderly patients often have reduced gastric acid production, which may alter the absorption of desiccated glandular products. Furthermore, the risk of interactions with concurrent medications (polypharmacy) is higher. Starting at the lowest possible dose is advised.
For optimal results and safety, follow these administration guidelines:
If you miss a dose, take it as soon as you remember. However, if it is nearly time for your next scheduled dose, skip the missed dose and resume your regular schedule. Do not double the dose to make up for a missed one, as this increases the risk of an acute immunological reaction.
Signs of an overdose of Sus Scrofa Spleen may include:
In the event of a suspected overdose, contact your local poison control center or seek emergency medical attention immediately. Bring the product container with you to the emergency room so the medical staff can identify the specific ingredients and concentrations.
> Important: Follow your healthcare provider's dosing instructions exactly. Do not adjust your dose or stop the medication without medical guidance, especially if being used for immune modulation.
Most patients tolerate Sus Scrofa Spleen well, but common reactions—particularly during the initial phase of treatment—include:
> Warning: Stop taking Sus Scrofa Spleen and call your doctor immediately if you experience any of the following:
Prolonged use of animal-derived glandulars can lead to 'feedback inhibition' of the patient's own organs. For example, long-term use of spleen extract might theoretically lead to a decreased endogenous splenic response or altered immune surveillance. There is also a theoretical risk of developing anti-porcine antibodies that could complicate future medical treatments involving porcine-derived products (such as porcine heart valves or insulin).
Currently, there are no FDA-mandated Black Box Warnings specifically for Sus Scrofa Spleen as a standalone ingredient. However, if the product is formulated with other potent substances (like certain thyroid hormones or anticoagulants), those specific warnings would apply. Patients must read the full label of their specific product carefully.
Report any unusual symptoms or persistent side effects to your healthcare provider. Monitoring of immune and endocrine markers may be necessary during long-term therapy.
Sus Scrofa Spleen is a biological product derived from animals. Its safety depends heavily on the source of the porcine tissue and the manufacturing process used to eliminate pathogens. Patients with a known allergy to pork or pork-derived products (such as heparin or certain insulins) must avoid this substance entirely.
No FDA black box warnings for Sus Scrofa Spleen. However, clinicians should remain vigilant for signs of 'Alpha-gal syndrome,' a red meat allergy that can be triggered by porcine-derived products.
If you are taking Sus Scrofa Spleen long-term, your healthcare provider may require periodic testing:
Sus Scrofa Spleen is generally not expected to cause sedation. However, if you experience dizziness, palpitations, or restlessness during the initial dosing phase, avoid driving or operating heavy machinery until you know how the substance affects you.
Alcohol may exacerbate the gastrointestinal side effects of Sus Scrofa Spleen and could potentially interfere with the absorption of active peptides. It is recommended to limit alcohol consumption while using this therapeutic agent.
Do not stop taking Sus Scrofa Spleen suddenly if you have been using it for an extended period, especially if it was prescribed for immune support. A gradual tapering of the dose may be necessary to prevent a 'rebound' effect in the immune system or endocrine pathways.
> Important: Discuss all your medical conditions, including any history of organ transplant or cancer, with your healthcare provider before starting Sus Scrofa Spleen.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking. The complexity of Sus Scrofa Spleen makes it prone to interactions that may not be immediately obvious.
Sus Scrofa Spleen must NEVER be used in the following circumstances:
Conditions requiring careful risk-benefit analysis include:
Patients who are sensitive to other porcine-derived medical products may also react to Sus Scrofa Spleen. These include:
> Important: Your healthcare provider will evaluate your complete medical history, including any rare allergies or family history of endocrine disorders, before prescribing Sus Scrofa Spleen.
Sus Scrofa Spleen is generally not recommended during pregnancy. It is often categorized similarly to FDA Pregnancy Category C (risk cannot be ruled out). The primary concerns are its Estrogen and Androgen Receptor Agonist activities, which could theoretically interfere with the delicate hormonal balance required to maintain a healthy pregnancy. There are no well-controlled studies in pregnant women to determine if it causes fetal harm or affects reproductive capacity.
It is unknown whether the peptides or hormonal components of Sus Scrofa Spleen pass into human breast milk. Because many proteins and hormones are excreted in milk, and because the infant's immune and endocrine systems are still developing, the use of this extract while breastfeeding is generally discouraged. A decision should be made whether to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.
The safety and effectiveness of Sus Scrofa Spleen in children have not been established. Due to the potential for immunomodulation and endocrine disruption, it should only be used in pediatric cases under the strict supervision of a specialist. It is not approved for general use in children under the age of 18.
Clinical studies of Sus Scrofa Spleen did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects. In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy.
In patients with renal impairment, the clearance of amino acids and small peptides may be reduced. While no specific GFR-based dosing scales exist, clinicians should monitor for signs of nitrogenous waste buildup or mineral imbalances if high doses are used.
Patients with Child-Pugh Class B or C hepatic impairment should be monitored closely. The liver's role in processing the 'Aromatic Amino Acid [EPC]' components and the 'l-Triiodothyronine [EPC]' components means that liver failure could lead to unpredictable systemic levels of these active fractions.
> Important: Special populations require individualized medical assessment and frequent monitoring to ensure that the biological activity of the extract does not cause unintended systemic effects.
Sus Scrofa Spleen operates via a multi-pathway biological response. Its primary molecular mechanism involves the modulation of the immune system through splenic peptides like Tuftsin and Splenopentin. Tuftsin binds to specific receptors on macrophages and polymorphonuclear leukocytes, stimulating phagocytosis and the release of interleukin-1 (IL-1). Splenopentin (corresponding to the 32-34 amino acid sequence of the splenic hormone splenin) enhances T-cell differentiation.
Additionally, the extract acts as an Acetylcholine Release Inhibitor, likely through presynaptic modulation of calcium channels, which accounts for its effects on the autonomic nervous system. The Estrogen and Androgen Receptor Agonist activities suggest that steroidal components or mimics within the porcine tissue can translocate to the nucleus and initiate gene transcription related to growth and metabolism.
The onset of action for the immunomodulatory effects is typically delayed, taking several days to weeks of consistent dosing to observe changes in white blood cell activity. However, the hormonal and neurotransmitter effects (such as changes in heart rate or gastric motility) may occur within hours of administration. Tolerance to the immunomodulatory effects is rarely reported, but 'escape' from the hormonal effects can occur as the body's homeostatic mechanisms adjust.
| Parameter | Value |
|---|---|
| Bioavailability | Variable (Peptides <15%) |
| Protein Binding | High (Albumin-bound fractions) |
| Half-life | 2 - 6 hours (Peptide components) |
| Tmax | 1 - 3 hours (Oral administration) |
| Metabolism | Systemic Proteolysis / Hepatic |
| Excretion | Renal (80%), Fecal (20%) |
Sus Scrofa Spleen is classified as a Non-Standardized Animal Allergenic Extract. It shares therapeutic space with other glandular extracts (like bovine thymus or porcine thyroid) and is often grouped with Vitamin C and l-Triiodothyronine in complex regulatory filings.
Common questions about Sus Scrofa Spleen
Sus Scrofa Spleen is primarily used in glandular therapy and homeopathy to support immune system function and address perceived splenic deficiencies. It is also utilized as a non-standardized allergenic extract for desensitization in patients with specific animal protein sensitivities. Some practitioners use it for its purported ability to modulate hormonal balance, given its androgen and estrogen receptor agonist properties. However, many of these uses are based on traditional practice rather than large-scale clinical trials. Always consult a healthcare provider before using it for any medical condition.
The most frequently reported side effects include mild gastrointestinal distress, such as nausea or bloating, and occasional headaches. Some patients may experience a temporary flushing of the skin or a slight increase in heart rate shortly after taking the supplement. These symptoms are often mild and tend to resolve as the body becomes accustomed to the porcine proteins. However, more significant reactions like skin rashes or irritability can occur. If side effects persist or worsen, it is important to contact a medical professional.
It is generally advisable to limit or avoid alcohol consumption while taking Sus Scrofa Spleen. Alcohol can irritate the gastrointestinal lining, potentially worsening the digestive side effects of the extract. Furthermore, alcohol may interfere with the absorption of the delicate peptides and proteins that are central to the drug's mechanism of action. Because the extract can influence metabolic and hormonal pathways, alcohol's effect on the liver could also lead to unpredictable results. Discuss your alcohol intake with your doctor to ensure safety.
Sus Scrofa Spleen is not recommended for use during pregnancy due to a lack of comprehensive safety data. The extract contains components that act as estrogen and androgen receptor agonists, which could potentially disrupt the hormonal environment necessary for fetal development. There is also the risk of an allergic reaction to porcine proteins, which could be dangerous for both the mother and the baby. Most healthcare providers suggest avoiding all non-essential glandular extracts during pregnancy. If you are pregnant or planning to become pregnant, talk to your obstetrician.
The time it takes to see results from Sus Scrofa Spleen depends on the condition being treated. For immune support and immunomodulation, it may take several weeks of consistent use before a noticeable difference in health or lab markers occurs. In contrast, effects related to its neurotransmitter or hormonal components, such as changes in energy levels or heart rate, might be felt within a few hours of the first few doses. Because it works through complex biological pathways, patience and consistent monitoring by a healthcare provider are necessary. Do not increase the dose if you do not see immediate results.
While Sus Scrofa Spleen is not typically associated with a severe withdrawal syndrome, it is generally best not to stop taking it suddenly if you have used it for a long time. Sudden discontinuation could lead to a 'rebound' effect where the immune or endocrine symptoms you were treating briefly worsen. A gradual reduction in dosage, known as tapering, allows your body's own organs to resume their normal signaling roles. Always follow a tapering schedule provided by your healthcare professional. Stopping any medication abruptly should only be done under medical supervision.
If you miss a dose of Sus Scrofa Spleen, take it as soon as you remember. If it is almost time for your next scheduled dose, skip the missed dose and continue with your regular routine. It is important not to take two doses at once to compensate for the one you missed, as this can increase the risk of an adverse reaction or stomach upset. Keeping a consistent schedule helps maintain steady levels of the extract's active components in your system. If you frequently miss doses, consider using a pill reminder or app.
Weight gain is not a commonly reported side effect of Sus Scrofa Spleen, but it is theoretically possible due to its androgen receptor agonist activity. Androgens can influence muscle mass and fluid retention, which might lead to changes in body weight for some individuals. Additionally, if the extract influences thyroid function through its l-Triiodothyronine components, it could affect metabolism and appetite. Most weight changes associated with this supplement are minor. If you notice significant or rapid weight gain, consult your doctor to rule out other underlying causes.
Sus Scrofa Spleen has the potential to interact with several types of medications, particularly immunosuppressants, thyroid hormones, and blood thinners. Because it modulates the immune system and contains hormonal precursors, it can either block or enhance the effects of prescription drugs. For example, taking it with an immunosuppressant could make the medication less effective, increasing the risk of disease flares. It is critical to provide your doctor with a full list of all medications and supplements you are taking. This allows them to check for potential contraindications and adjust your treatment plan accordingly.
Because Sus Scrofa Spleen is a biological extract and often regulated as a dietary supplement or homeopathic remedy, the concept of 'generic' vs. 'brand name' is different than for synthetic drugs. It is available from many different manufacturers under various trade names and as a bulk ingredient. However, these products are not necessarily bioequivalent, meaning one brand may have a different concentration of active peptides than another. When choosing a product, look for those that follow Good Manufacturing Practices (GMP) and are transparent about their sourcing. Always stick with the specific brand or formulation recommended by your healthcare provider.